Next Article in Journal
The Long Noncoding RNA HOTAIR in Breast Cancer: Does Autophagy Play a Role?
Next Article in Special Issue
Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model
Previous Article in Journal
Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets
Previous Article in Special Issue
Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(11), 2322;

The Hypothalamic–Pituitary Axis and Autoantibody Related Disorders

Department of Biomedical Sciences, University of Cagliari, 09042 Monserrato, Cagliari, Italy
Author to whom correspondence should be addressed.
Received: 12 September 2017 / Revised: 27 October 2017 / Accepted: 1 November 2017 / Published: 3 November 2017
Full-Text   |   PDF [238 KB, uploaded 3 November 2017]


This review summarized different studies reporting the presence of autoantibodies reacting against cells of the pituitary (APAs) and/or hypothalamus (AHAs). Both APAs and AHAs have been revealed through immunofluorescence using different kinds of substrates. Autoantibodies against gonadotropic cells were mainly found in patients affected by cryptorchidism and hypogonadotropic hypogonadism while those against prolactin cells were found in different kinds of patients, the majority without pituitary abnormalities. APAs to growth hormone (GH) cells have been associated with GH deficiency while those against the adrenocorticotropic cells have distinguished central Cushing’s disease patients at risk of incomplete cure after surgical adenoma removal. AHAs to vasopressin cells have identified patients at risk of developing diabetes insipidus. APAs have been also found together with AHAs in patients affected by idiopathic hypopituitarism, but both were also present in different kinds of patients without abnormalities of the hypothalamic–pituitary axis. Despite some data being promising, the clinical use of pituitary and hypothalamus autoantibodies is still limited by the low diagnostic sensitivity, irreproducibility of the results, and the absence of autoantigen/s able to discriminate the autoimmune reaction involving the pituitary or the hypothalamus from the other autoimmune states. View Full-Text
Keywords: autoimmunity; pituitary; hypothalamus; autoantibodies autoimmunity; pituitary; hypothalamus; autoantibodies
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Cocco, C.; Brancia, C.; Corda, G.; Ferri, G.-L. The Hypothalamic–Pituitary Axis and Autoantibody Related Disorders. Int. J. Mol. Sci. 2017, 18, 2322.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top